default author photo

Richard Newcomb

Harvard University - Massachusetts General Hospital

SCHOLARLY PAPERS

1

DOWNLOADS

77

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase 2 Multicenter Trial of Ruxolitinib to Treat Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation

Number of pages: 31 Posted: 10 May 2024
Massachusetts General Hospital - Hematopoietic Cell Transplant and Cell Therapy Program, Harvard University - Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, Case Western Reserve University, School of Medicine, Case Comprehensive Cancer Center, Mayo Clinic, Medical College of Wisconsin, City of Hope, H. Lee Moffitt Cancer Center & Research Institute, University of Utah, affiliation not provided to SSRN, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital and Harvard University - Massachusetts General Hospital
Downloads 77 (823,616)

Abstract:

Loading...

ruxolitinib, chronic graft-versus-host disease, bronchiolitis obliterans syndrome, pulmonary disease, allogeneic hematopoietic cell transplantation